QUETIAPINE CINFA 300 mg PROLONGED-RELEASE TABLETS

Introduction

Package Leaflet: Information for the Patient

quetiapine cinfa 300 mg prolonged-release tablets EFG

Quetiapine

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information

1. What quetiapine cinfa is and what it is used for
2. What you need to know before you take quetiapine cinfa
3. How to take quetiapine cinfa
4. Possible side effects
5. Storage of quetiapine cinfa
6. Contents of the pack and other information

1. What quetiapine cinfa is and what it is used for

quetiapine cinfa contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. quetiapine cinfa can be used to treat several diseases, such as:

• Bipolar depression and major depressive episodes in major depressive disorder: for which you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose appetite, or cannot sleep.
• Mania: for which you may feel very excited, euphoric, agitated, enthusiastic, or hyperactive, or show poor judgment, including being aggressive or violent.
• Schizophrenia: for which you may hear or feel things that are not there, believe things that are not true, or feel abnormally suspicious, anxious, confused, guilty, tense, or depressed.

When quetiapine cinfa is used to treat major depressive episodes in major depressive disorder, it will be taken in addition to another medication that is being used to treat this disease.

Your doctor may continue to prescribe quetiapine cinfa even when you are feeling better.

2. What you need to know before you take quetiapine cinfa

Do not take quetiapine cinfa

• if you are allergic to quetiapine or any of the other ingredients of this medicine (listed in section 6).
• if you are taking any of the following medicines:
• • Some medicines for HIV.
  • Medicines of the azole type (for fungal infections).
  • Erythromycin or clarithromycin (for infections).
  • Nefazodone (for depression).

If you are in doubt, consult your doctor or pharmacist before taking quetiapine.

Warnings and precautions

Consult your doctor or pharmacist before starting to take quetiapine cinfa:

• if you, or a family member, have or have had any heart problems, such as heart rhythm problems, muscle weakness, or heart inflammation, or if you are taking any medication that may affect your heart rate.
• if you have low blood pressure.
• if you have had a stroke, especially if you are an elderly patient.
• if you have liver problems.
• if you have ever had an epileptic seizure (convulsion).
• if you suffer from depression or other conditions that are treated with antidepressants. The use of these medications with quetiapine cinfa may cause serotonin syndrome, a potentially life-threatening condition (see "Other medicines and quetiapine cinfa").
• if you have diabetes or are at risk of developing diabetes. If so, your doctor may monitor your blood sugar levels while you are taking quetiapine cinfa.
• if you know you have had low white blood cell counts in the past (which may or may not have been caused by other medications).
• if you are an elderly patient with dementia (loss of brain function). If so, you should not take quetiapine cinfa because the group of medicines to which quetiapine belongs may increase the risk of stroke, or in some cases the risk of death, in elderly patients with dementia.
• if you are an elderly patient with Parkinson's disease/parkinsonism.
• if you or a family member have a history of blood clots, as medications like this have been associated with the formation of blood clots.
• if you have or have had a condition in which your breathing is interrupted for short periods during normal nighttime sleep (called "sleep apnea") and are taking medications that reduce normal brain activity ("depressants").
• if you have or have had a condition in which you cannot completely empty your bladder (urinary retention), have an enlarged prostate, an obstruction in your intestine, or high pressure inside your eye. These conditions may be caused by medications (called "anticholinergics") that affect how nerve cells work, to treat certain medical conditions.
• if you have a history of alcohol or drug abuse.

Tell your doctor immediately if you experience any of the following after taking quetiapine cinfa:

• A combination of fever, severe muscle stiffness, sweating, or a decrease in level of consciousness (a disorder called "neuroleptic malignant syndrome"). Immediate medical treatment may be necessary.
• Fast and irregular heartbeats, even when at rest, palpitations, breathing problems, chest pain, or unexplained fatigue. Your doctor should examine your heart and, if necessary, refer you to a cardiologist immediately.
• Uncontrolled movements, mainly of your face or tongue.
• Dizziness or feeling very drowsy. This can increase the risk of accidental injuries (falls) in elderly patients.
• Seizures (convulsions).
• Prolonged and painful erections (priapism).

These disorders can be caused by this type of medication.

Tell your doctor as soon as possible if you experience:

• Fever, pseudo-flu syndrome, sore throat, or any other infection that may be the result of a low white blood cell count, which may require discontinuation of treatment with quetiapine cinfa and/or additional treatment.
• Constipation with persistent abdominal pain, or constipation that has not responded to treatment, which can lead to more serious intestinal blockage problems.

Thoughts of suicide and worsening of your depression

If you are depressed, you may sometimes think of harming yourself or committing suicide. This can increase when you first start treatment, as all these medications take time to work, usually around two weeks but sometimes more. These thoughts can also increase if you stop taking your medication abruptly.

You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of suicidal thoughts and/or suicidal behavior in young adults under 25 years of age with depression.

If at any time you think of harming yourself or committing suicide, contact your doctor or go to a hospital immediately. It may help to tell a relative or close friend that you are depressed and ask them to read this leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behavior.

Severe skin reactions (SCARs)

With the use of this medication, very rare severe skin reactions (SCARs) have been reported, which can be life-threatening or fatal. These are commonly manifested as:

• Stevens-Johnson syndrome (SSJ), a widespread rash with blisters and peeling of the skin, particularly around the mouth, nose, eyes, and genitals.
• Toxic epidermal necrolysis (NET), a more severe form that causes extensive peeling of the skin.
• Drug reaction with eosinophilia and systemic symptoms (DRESS), which consists of flu-like symptoms with a rash, fever, swollen lymph nodes, and abnormal blood test results (including an increase in the number of white blood cells (eosinophilia) and elevated liver enzymes).
• Acute generalized exanthematous pustulosis (AGEP), small pus-filled blisters.
• Erythema multiforme (EM), skin rashes with irregular red patches that itch.

If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.

Weight gain

Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.

Children and adolescents

quetiapine cinfa is not indicated for use in children or adolescents under 18 years of age.

Other medicines and quetiapine cinfa

Tell your doctor if you are taking, have recently taken, or might take any other medicines.

Do not take quetiapine cinfa if you are using any of the following medicines:

• Some medicines for HIV.
• Medicines of the azole type (for fungal infections).
• Erythromycin or clarithromycin (for infections).
• Nefazodone (for depression).

Tell your doctor if you are using any of the following medicines:

• Medicines for epilepsy (such as phenytoin or carbamazepine).
• Medicines for high blood pressure.
• Barbiturates (for difficulty sleeping).
• Thioridazine or Lithium (other antipsychotic medicines).
• Antidepressants. These medications can interact with quetiapine cinfa and you may experience symptoms such as involuntary muscle contractions and rhythmic movements of the muscles, including the muscles that control eye movement, agitation, hallucinations, coma, excessive sweating, tremors, exaggerated reflexes, increased muscle tone, and body temperature above 38°C (serotonin syndrome). Contact your doctor when you experience these symptoms.
• Medicines that affect your heart rate, such as medicines that can cause an imbalance in electrolytes (low potassium or magnesium levels) such as diuretics (medicines to urinate) or certain antibiotics (medicines to treat infections).
• Medicines that can cause constipation.
• Medicines (called "anticholinergics") that affect how nerve cells work, to treat certain medical conditions.

Before stopping any of your medicines, consult your doctor first.

quetiapine cinfa with food, drinks, and alcohol

• quetiapine cinfa may be affected by food and should be taken at least one hour before a meal or before bedtime.
• Be careful with the amount of alcohol you drink. This is because the combined effect of quetiapine cinfa and alcohol can make you drowsy.
• Do not drink grapefruit juice while taking quetiapine cinfa. It can affect how the medicine works.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. You should not take quetiapine cinfa during pregnancy, unless your doctor has advised you to do so. You should not use quetiapine cinfa if you are breastfeeding.

The following symptoms that may represent withdrawal symptoms may occur in the newborn, whose mothers have taken quetiapine in the third trimester of pregnancy (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you may need to contact your doctor.

Driving and using machines

quetiapine cinfa can cause symptoms such as drowsiness, dizziness, or changes in vision, and can reduce your reaction ability. These effects, as well as the disease itself, can make it difficult for you to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medication.

Effect on drug detection tests in urine

If you are undergoing a urine drug detection test, quetiapine cinfa may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when some analysis methods are used, even if you are not taking methadone or TCAs. If this happens, a more specific test can be performed.

quetiapine cinfa contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

3. How to take quetiapine cinfa

Follow the instructions for administration of this medicine exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and needs but will normally be between 150 mg and 800 mg.

• You will take your tablets once a day.
• Do not split, chew, or crush the tablets.
• Swallow your tablets whole with the help of water.
• Take the tablets without food (at least one hour before a meal or at bedtime, your doctor will indicate when).
• Do not drink grapefruit juice while taking quetiapine cinfa. It can affect how the medicine works.
• Do not stop taking your tablets even if you feel better, unless your doctor tells you to.

Liver problems

If you have liver problems, your doctor may change your dose.

Elderly patients

If you are an elderly patient, your doctor may change your dose.

Use in children and adolescents

quetiapine cinfa should not be used by children and adolescents under 18 years of age.

If you take more quetiapine cinfa than you should

If you take more quetiapine cinfa than your doctor has prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, Telephone 915 620 420, indicating the medicine and the amount ingested. Bring the quetiapine cinfa tablets with you.

If you forget to take quetiapine cinfa

If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for forgotten doses.

If you stop taking quetiapine cinfa

If you stop taking quetiapine cinfa abruptly, you may be unable to sleep (insomnia), or you may feel nauseous, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability.

Your doctor may suggest gradually reducing the dose before stopping treatment.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

If you experience any of the following serious adverse effects, stop taking quetiapine cinfaand go to your doctor or the nearest hospital:

Adverse EffectsFrequency

Frequent Adverse Effects(may affect up to 1 in 10 people)

• Suicidal thoughtsand worsening of your depression.

Uncommon Adverse Effects(may affect up to 1 in 100 people)

• Sudden fever, especially with irritated throatand other flu-like symptoms.This may be due to an abnormally low concentration of white blood cells.
• Skin reactionssuch as rash, hives, bumps, redness, itching, possibly with swelling of the face, eyelids, and lips. This may also cause difficulty breathing, dizziness, or shock.
• Seizuresor convulsions.
• Uncontrolled movements, mainly of the face or tongue (tardive dyskinesia).
• Sensation that the heart is poundingor beating rapidlyalong with dizziness or fainting. These may be symptoms of serious heart rhythm problems and, in severe cases, could be fatal.

Rare Adverse Effects(may affect up to 1 in 1,000 people)

• Sharp pain and/or swellingand redness in one leg; sudden sharp painin the chestthat may extend to the left arm or shortness of breath. This may be due to blood clots in the veins.
• Sharp pain in the upper abdomen, which may extend to the back, causing nausea and vomitingin some cases. This may be a symptom of pancreas inflammation.
• Constipation with persistent abdominal painor constipation that does not respond to treatment and may lead to a more serious intestinal blockage.
• Yellowing of the skin and eyes(jaundice), dark-colored urine, along with unusual fatigue or fever (symptom of hepatitis).
• Prolonged and painful erection.
• A combination of fever, sweating, muscle stiffness, feeling very dizzy or weak (a disorder called "neuroleptic malignant syndrome").

Very Rare Adverse Effects(may affect up to 1 in 10,000 people)

• Severe skin reactions with rash or blisters, irregular red spots and/or skin peeling, around the mouth, eyes, or genitals, often with feveror flu-like symptoms. These reactions can appear rapidly.
• Muscle painunexpectedly, sensitivity, or weakness. These may be the first symptoms of severe muscle degradation.

Unknown Frequency(frequency cannot be estimated from available data)

• Rapid appearance of red skin areas with small pus-filled bumps (small blisters filled with white/yellow liquid known as Acute Generalized Exanthematous Pustulosis (AGEP). See section 2.
• Skin rash with irregular red spots (erythema multiforme). See section 2.
• Heart muscle disorder (cardiomyopathy)
• Inflammation of the heart muscle (myocarditis)
• Condition with deficient blood flow in the brain (stroke). Typical signs may include sudden facial drooping, weakness in the arms, difficulty speaking, and inability to move or feel on one side of the body.

Drug rash with eosinophilia and systemic symptoms (DRESS): Widespread rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), enlarged lymph nodes, and other organs involved (drug rash with eosinophilia and systemic symptoms, also known as DRESS). If you develop these symptoms, stop using quetiapine and contact your doctor or seek immediate medical attention.

Do not worry if you see a tablet in your stoolafter taking quetiapine cinfa. As the tablet passes through the gastrointestinal tract, quetiapine is slowly released. The tablet shape remains undissolved and is eliminated in the stool. Therefore, even if you see a tablet in your stool, your dose of quetiapine has been absorbed.

Other Possible Adverse Effects:

Very Frequent Adverse Effects(may affect more than 1 in 10 people)

• Dizziness (may lead to falls), headache, dry mouth.
• Feeling of drowsiness (which may disappear over time as you continue taking quetiapine cinfa) (may lead to falls).
• Withdrawal symptoms (symptoms that occur when you stop taking quetiapine cinfa) include inability to sleep (insomnia), feeling nauseous, headache, diarrhea, vomiting, dizziness, and irritability. A gradual withdrawal over a period of at least 1 to 2 weeks is advised.
• Weight gain.
• Abnormal muscle movements. This includes difficulty initiating muscle movements, tremors, feeling of restlessness, or muscle stiffness without pain.
• Decrease in hemoglobin levels (protein in red blood cells that carries oxygen).
• Increase in certain fats (triglycerides and total cholesterol).

Frequent Adverse Effects(may affect up to 1 in 10 people)

• Fast heartbeat.
• Feeling that the heart is pounding, beating rapidly, or has irregular beats.
• Constipation, upset stomach (indigestion).
• Feeling of weakness.
• Swelling of arms or legs.
• Low blood pressure when standing. This may make you feel dizzy or faint (may lead to falls).
• Increased blood sugar levels.
• Blurred vision.
• Abnormal dreams and nightmares.
• Feeling more hungry.
• Feeling irritable.
• Disorder in speech and language.
• Difficulty breathing.
• Vomiting (mainly in elderly patients).
• Fever.
• Changes in the amount of thyroid hormones in the blood.
• Changes in the amount of certain blood cells.
• Increased amount of liver enzymes in the blood.
• Increased amount of prolactin hormone in the blood. This increase in prolactin could, in rare cases, lead to:
• • Both men and women having breast swelling and unexpected milk production.
  • In women, not having menstrual periods or having irregular periods.

Uncommon Adverse Effects(may affect up to 1 in 100 people)

• Unpleasant sensations in the legs (also called restless legs syndrome).
• Difficulty swallowing.
• Sexual dysfunction.
• Diabetes.
• Slower than normal heart rate that may occur when treatment is started and may be associated with low blood pressure and fainting.
• Difficulty urinating.
• Fainting (may lead to falls).
• Stuffy nose.
• Decrease in the amount of sodium in the blood.
• Worsening of pre-existing diabetes.
• Confusion.

Rare Adverse Effects(may affect up to 1 in 1,000 people)

• Breast swelling and unexpected milk production (galactorrhea).
• Menstrual disorder.
• Walking, talking, eating, or other activities while sleeping.
• Decrease in body temperature (hypothermia).
• A condition (called "metabolic syndrome") where you may have a combination of 3 or more of the following: increased fat around the abdomen, decreased "good" cholesterol (HDL-C), increased triglycerides in the blood, high blood pressure, and increased blood sugar.
• Increased creatine phosphokinase in the blood (substance from muscles).

Very Rare Adverse Effects(may affect up to 1 in 10,000 people)

• Inappropriate secretion of a hormone that controls urine volume.

Unknown Frequency(frequency cannot be estimated from available data)

• Withdrawal symptoms may occur in newborns of mothers who have used quetiapine cinfa during pregnancy.
• Inflammation of blood vessels (vasculitis), often with a skin rash with small red or purple spots.

Some adverse effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased number of certain types of blood cells, decreased number of red blood cells, increased creatine phosphokinase in the blood (a substance from muscles), decreased amount of sodium in the blood, and an increased amount of prolactin hormone in the blood.

The increases in prolactin hormone could, in rare cases, lead to:

• Both men and women having breast swelling and unexpected milk production.
• In women, not having menstrual periods or having irregular periods.

Your doctor may ask you to have blood tests from time to time.

Adverse Effects in Children and Adolescents

The same adverse effects that can occur in adults can also occur in children and adolescents.

The following adverse effects have been observed more frequently in children and adolescents or have not been observed in adults:

Very Frequent Adverse Effects(may affect more than 1 in 10 people)

• Increased amount of a hormone called prolactin in the blood. The increases in prolactin hormone could, in rare cases, lead to:
• • Both boys and girls having breast swelling and unexpected milk production.
  • In girls, not having menstrual periods or having irregular periods.
• Increased appetite.
• Vomiting.
• Abnormal muscle movements. This includes difficulty initiating muscle movements, tremors, feeling of restlessness, or muscle stiffness without pain.
• Increased blood pressure.

Frequent Adverse Effects(may affect up to 1 in 10 people)

• Feeling of weakness, fainting (may lead to falls).
• Stuffy nose.
• Feeling of irritability.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Qutiapine Cinfa

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the packaging and on the blister after EXP. The expiration date is the last day of the month indicated.

Store in the original packaging to protect it from moisture.

This medicine does not require any special storage temperature.

After the first opening of the HDPE bottle, the product must be used within 60 days.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Qutiapine Cinfa

• The active ingredient is quetiapine. Qutiapine cinfa tablets contain 300 mg of quetiapine (as quetiapine fumarate).

• The other ingredients (excipients) are:

Core: hypromellose, microcrystalline cellulose, anhydrous sodium citrate, magnesium stearate. Coating: titanium dioxide (E171), hypromellose, macrogol/PEG 400, polysorbate 80, yellow iron oxide (E172), red iron oxide (E172), and black iron oxide (E172).

Appearance of the Product and Package Contents

Qutiapine cinfa 300 mg prolonged-release tablets EFG

They are film-coated, light yellow, biconvex, oblong, and engraved with "Q 300" on one side.

Packaging of 10, 20, 30, 50, 50x1 (single-dose perforated blister) (hospital packaging), 56 (calendar packaging), 60, 90, and 100 tablets.

HDPE bottles containing 60 tablets.

Not all packaging sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta.

31620 Huarte (Navarra) - Spain

Manufacturer

TEVA Pharmaceutical Works Private Limited Company

Pallagi út 13, H-4042 Debrecen

Hungary

Pharmachemie B.V.

Swensweg 5, P.O. Box 552 NL 2003 RN Haarlem

Netherlands

Teva Czech Industries s.r.o.

Ostravska 29, c.p. 305, Building No 80 Small OSD and Building No 881 NOSD

74770 Opava-Komarov

Czech Republic

TEVA OPERATIONS POLAND SP.Z.O.O.

ul. Mogilska 80. 31-546, Krakow

Poland

Teva Pharma, S.L.U.

C/C, n. 4, Polígono Industrial Malpica, 50016 Zaragoza

Spain

Merckle GmbH

Ludwig-Merckle-Straße 3, 89143 Blaubeuren

Germany

Date of the Last Revision of this Leaflet:June 2024

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/75502/P_75502.html

QR code to: https://cima.aemps.es/cima/dochtml/p/75502/P_75502.html